Tech Company Financing Transactions

Cellcolabs Funding Round

Cellcolabs, operating out of Solna, scored $8.7 million from private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Retzius väg 8
Solna, 171 65
Sweden

Phone

Undisclosed

Website

www.cellcolabs.com

Email Address

[email protected]

Overview

Cellcolabs is a biotech company specialising in Industrial GMP production of high quality stem cells (Mesenchymal Stem Cells). The company is founded on the research conducted by Professor Katarina Le Blanc and co-founded by healthcare entrepreneur Per Båtelson, Maria Rankka and Norrsken. For two decades, Katarina's team at the Karolinska Institute has been dedicated to advancing stem cell research.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Maria Rankka

        

Chief Executive Officer

Mattias Bernow

        

Chief Medical Officer

Heidi Stensmyren

        

Chief Operating Officer

Petter Hallman

        

VP - Bus. Development

Michael Luxemburg

        

VP - Manufacturing

Lina Sörvik

        

VP - R & D

Nadir Kadri

        

VP - Regulatory Affairs

Linda Ranehamn

        

Browse more venture capital transactions:

Prev: 3/5/2024: mPATH Health venture capital transaction
Next: 3/5/2024: Openprise venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary